Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1178

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 4
Chunk 1178
---
 property security agreement with the holder, pursuant to which the Company granted a security interest on all assets
of the Company, including all intellectual property of the Company, for the benefit of the holders, to secure the Company’s obligations
under the Note and the other transaction documents. In addition, the holder was granted piggyback registration rights for the shares
of common stock issued under the Purchase Agreement and shares of common stock issuable upon conversion of the Note (collectively, “Registrable
Securities”). At any time while there are any Registrable Securities of holder outstanding, if the Company proposes to register
any of its securities either for its own account or for the account of other security holders (other than a registration statement relating
solely to employee benefit plans on Form S-8 or a Commission Rule 145 transaction on Form S-4), the holder is entitled to include its
Registrable Securities in the registration. Notwithstanding, the Company and underwriters in an underwritten registration may exclude
some or all of the Registrable Securities from the underwritten registration if the underwriters believe that including the Registrable
Securities would adversely affect the underwritten offering.

At
any time within the 12 months closing, upon any issuance by the Company or any of its subsidiaries of debt or common stock or common
stock equivalents for cash consideration, indebtedness or a combination of units thereof, other than in an underwritten public offering
(a “Subsequent Financing”), the investor will have the right to participate up to its investment amount in the Note, but
not more than 25% of the Subsequent Financing, on the same terms, conditions and price provided for in the Subsequent Financing.

Until
the Company has consummated a Qualified Offering which results in a listing of the common stock onto a national securities exchange,
if the Company engages in any future financing transactions with a third-party investor, if the holder determines that the terms of the
subsequent investment are preferable in any respect to the terms of the securities of the Company issued to the Holder pursuant to the
terms of the Purchase Agreement, the holder will have the right to amend and restate such securities to include the preferable term or
terms.

89

Notes
Payable, related party

The
Company’s Chief Executive Officer (CEO) has loaned the Company working capital since inception. The balance of the loans to the
CEO as of December 31, 2024 and 2023 was $146,432 and $358,479, respectively